Development of active pharmaceutical ingredients for clinical development: Synthesis of a gamma secretase modulator

被引：0
|
作者：
Caron, Stephane [1 ]
机构：
[1] Pfizer Worldwide RD, Chem RD, MS 8220-2432, Groton, CT USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
302
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Development of a chemoenzymatic process for a gamma secretase modulator
    Wong, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [2] Process development for active pharmaceutical ingredients following a developmental cascade
    Adler, Carmen
    Brunner, Juerg
    Fichtner, Claudia
    Kueng, Peter
    Levis, Michael K.
    Ruchti, Hans-Rudolf
    Sjoeberg, Anders
    Weber, Beat
    CHIMIA, 2006, 60 (09) : 523 - 529
  • [3] Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients
    Burke, Anthony J.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (01) : 37 - 46
  • [4] Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)
    Laha, Joydev K.
    Zhou, Jianrong Steve
    SYNTHESIS-STUTTGART, 2024, 56 (04): : III - IV
  • [5] Challenges in the development of hydrate phases as active pharmaceutical ingredients - An example
    Feth, Martin P.
    Nagel, Norbert
    Baumgartner, Bruno
    Broeckelmann, Martin
    Rigal, David
    Otto, Bernhard
    Spitzenberg, Michael
    Schulz, Markus
    Becker, Bernd
    Fischer, Franceska
    Petzoldt, Christine
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 42 (1-2) : 116 - 129
  • [6] Asymmetric synthesis of active pharmaceutical ingredients
    Farina, Vittorio
    Reeves, Jonathan T.
    Senanayake, Chris H.
    Song, Jinhua J.
    CHEMICAL REVIEWS, 2006, 106 (07) : 2734 - 2793
  • [7] Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients
    Daniel Capaldi
    Kathy Ackley
    Doug Brooks
    Judy Carmody
    Ken Draper
    Rao Kambhampati
    Matthias Kretschmer
    Daren Levin
    James McArdle
    Bernhard Noll
    Ramesh Raghavachari
    Ipsita Roymoulik
    B. P. (Bob) Sharma
    René Thürmer
    Fran Wincott
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 611 - 626
  • [8] Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients
    Capaldi, Daniel
    Ackley, Kathy
    Brooks, Doug
    Carmody, Judy
    Draper, Ken
    Kambhampati, Rao
    Kretschmer, Matthias
    Levin, Daren
    McArdle, James
    Noll, Bernhard
    Raghavachari, Ramesh
    Roymoulik, Ipsita
    Sharma, B. P.
    Thuermer, Rene
    Wincott, Fran
    DRUG INFORMATION JOURNAL, 2012, 46 (05): : 611 - 626
  • [9] Application of crystallization technologies to process development and manufacture of active pharmaceutical ingredients
    Rose, PR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3344 - U3345
  • [10] Combined high-throughput and mechanistic approach to the development of catalytic reactions for the synthesis of active pharmaceutical ingredients
    Leitch, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
12345